- Home
- CYH vs NAUT Comparison
CYH vs NAUT Comparison
Compare CYH & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CYH | NAUT |
|---|---|---|
| Founded | 1985 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 432.2M | 383.5M |
| IPO Year | 2000 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CYH | NAUT |
|---|---|---|
| Price | $2.71 | $2.74 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | $3.28 | ★ $4.00 |
| AVG Volume (30 Days) | ★ 1.3M | 375.8K |
| Earning Date | 04-21-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 196.67 | 16.07 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,485,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.17 | $992.86 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.39 | $0.62 |
| 52 Week High | $4.43 | $4.31 |
Technical Indicators
Market Signals| Indicator | CYH | NAUT |
|---|---|---|
| Relative Strength Index (RSI) | 40.62 | 52.04 |
| Support Level | $2.71 | $2.28 |
| Resistance Level | $3.25 | $3.17 |
| Average True Range (ATR) | 0.11 | 0.20 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 4.92 | 51.72 |
Price Performance
Historical ComparisonAbout CYH Community Health Systems Inc.
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.